Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Webinars

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

Bridging the Efficacy-Effectiveness Gap in Rare Diseases
Webinars

Bridging the Efficacy-Effectiveness Gap in Rare Diseases

June 18th, 2026 1 minute read

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials
Webinars

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 9th, 2026 1 minute read

About This Webinar Bayesian methods continue to gain momentum as an alternative approach to traditional clinical tria...

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development
Webinars

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development

June 3rd, 2026 1 minute read

About This Webinar In this session, we explore real-world use cases where AI and LLMs (Large Language Models) have be...